China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. It offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. The company provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of July 31, 2021, its end-customer base includes 70 pharmaceutical companies, 12 chain pharmacies, and 59 hospitals in 10 provinces and municipalities in China, including Jiangsu, Hubei, Shandong, Guangdong, Liaoning, Anhui, Henan, Jiangxi, Heilongjiang, and Hainan. The company was founded in 2005 and is based in Taizhou, China.
IPO Year: 2019
Exchange: NASDAQ
Website: sxtchina.com
| Date | Price Target | Rating | Analyst |
|---|
6-K - China SXT Pharmaceuticals, Inc. (0001723980) (Filer)
424B5 - China SXT Pharmaceuticals, Inc. (0001723980) (Filer)
6-K - China SXT Pharmaceuticals, Inc. (0001723980) (Filer)
424B5 - China SXT Pharmaceuticals, Inc. (0001723980) (Filer)
S-8 - China SXT Pharmaceuticals, Inc. (0001723980) (Filer)
6-K - China SXT Pharmaceuticals, Inc. (0001723980) (Filer)
6-K - China SXT Pharmaceuticals, Inc. (0001723980) (Filer)
6-K - China SXT Pharmaceuticals, Inc. (0001723980) (Filer)
6-K - China SXT Pharmaceuticals, Inc. (0001723980) (Filer)
EFFECT - China SXT Pharmaceuticals, Inc. (0001723980) (Filer)